Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Polio could be wiped out in Nigeria thanks to improved vaccine

16.10.2008
A recently introduced polio vaccine is four times more effective at protecting children than previous vaccines and has the potential to eradicate type 1 polio in Nigeria if it reaches enough children, according to a study published today in the New England Journal of Medicine.

Nigeria is one of only four countries in the world where polio has yet to be eliminated and 82% of global cases so far this year have been in Nigeria. Polio is highly infectious and it primarily affects children under five years of age. A small minority of infected people develop permanent paralysis, which can be fatal.

The monovalent oral poliovirus vaccine, known as mOPV1, has been used in Nigeria since February 2006 and the number of reported cases of polio in the country fell by 75% between 2006 and 2007.

With each dose of mOPV1 received, a child in Nigeria has a 67% chance of being protected against type 1 paralytic poliomyelitis, according to the new study, which was carried out by researchers from the MRC Centre for Outbreak Analysis and Modelling at Imperial College London, working with international colleagues. The standard trivalent vaccine in the same setting had an efficacy of 16%.

Although the monovalent vaccine is proving very effective, many more children need to be immunised against polio if the virus is to be eliminated in Nigeria, say the researchers. In the North West zone of the country, where the majority of new cases are found, 21% of children report never having received a single dose of the vaccine and a further 55% have received fewer than the recommended four doses.

The new research comes just 4 months after the World Health Assembly expressed alarm over a dramatic increase in type 1 cases in Nigeria because of poor immunisation in the north of the country. The Government of Nigeria subsequently established a Presidential Task Force to identify barriers to immunisation and potential solutions.

A previous study, published in the Lancet in 2007, looked at how well polio vaccines were working in Northern India and revealed that there, although mOPV1 was three times more effective than the trivalent vaccine, environmental factors compromised the efficacy of both the trivalent and monovalent oral vaccines. The researchers behind today’s study say that the mOPV1’s effectiveness is not as badly compromised by environmental conditions in Nigeria. This means that the key to eliminating polio in Nigeria is reaching sufficient numbers of children with the vaccine, demonstrating the feasibility of elimination in Africa.

Helen Jenkins, the corresponding author of the study from the MRC Centre for Outbreak Analysis and Modelling at Imperial College London, said: “Nigeria and India are responsible for the vast majority of new global polio cases. In Nigeria, we now have an effective vaccine to use and we’ve seen the start of improvements in vaccine uptake. These last pockets of unvaccinated children now need to be reached to achieve elimination in Nigeria and this in turn will have a dramatic impact on the prospects of worldwide eradication.”

The researchers reached their conclusions after analysing the vaccination histories of 21,815 children with acute flaccid paralysis, 14% of whom had polio, collected between January 2001 and December 2007.

This study was supported by the Medical Research Council and the Royal Society.

Laura Gallagher | alfa
Further information:
http://www.imperial.ac.uk

Further reports about: Analysis Polio Vaccine mOPV1 paralytic poliomyelitis poliovirus vaccine

More articles from Studies and Analyses:

nachricht New study: How does Europe become a leading player for software and IT services?
03.04.2017 | Fraunhofer-Institut für System- und Innovationsforschung (ISI)

nachricht Reusable carbon nanotubes could be the water filter of the future, says RIT study
30.03.2017 | Rochester Institute of Technology

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

Copper hydroxide nanoparticles provide protection against toxic oxygen radicals in cigarette smoke

29.05.2017 | Life Sciences

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>